Tactile Systems Technology, Inc.
Financials
Valuation Metrics
Tactile Systems Technology, Inc.'s Market Cap is $501M. At end of 2025 it was $649M. Ranked #2790 of 3,121 in US market (top 89%), #1222 of 1,463 on NASDAQ (top 84%), #170 of 205 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $501M | US#2,790/3,121 Sec#170/205 |
| Revenue | $350M | US#2,391/3,121 Sec#151/205 |
| Net Income | $25M | US#2,067/3,121 Sec#103/205 |
| Total Assets | $280M | US#2,934/3,121 Sec#180/205 |
| Net Assets | $224M | US#2,646/3,121 Sec#159/205 |
| Employees | 1,086 | US#1,961/3,121 Sec#131/205 |
| Value | ||
| P/E | 20.14x | US#1,158/3,121 Sec#29/205 |
| P/B | 2.24x | US#1,410/3,121 Sec#68/205 |
| PEG | 0.31x | US#449/3,121 Sec#15/205 |
| P/S | 1.43x | US#1,009/3,121 Sec#68/205 |
| EV/EBITDA | 10.09x | US#856/3,121 Sec#26/205 |
| FCF Yield | 5.34% | US#1,364/3,121 Sec#63/205 |
| Profitability | ||
| ROE | 11.11% | US#1,249/3,121 Sec#62/205 |
| ROA | 8.89% | US#567/3,121 Sec#33/205 |
| Op. Margin | 10.00% | US#1,596/3,121 Sec#79/205 |
| Revenue Growth | 17.22% | US#805/3,121 Sec#53/205 |
| Earnings Growth | 64.52% | US#417/3,121 Sec#17/205 |
| Financial Health | ||
| Debt Ratio | 24.94% | US#276/3,121 Sec#28/205 |
| Total Debt | $14M | US#2,802/3,121 Sec#180/205 |
| FCF | $27M | US#2,140/3,121 Sec#125/205 |
| Cash | $70M | US#2,430/3,121 Sec#150/205 |
| Current Ratio | 4.12x | US#563/3,121 Sec#54/205 |
| Net Debt/EBITDA | -1.26x | US#253/3,121 Sec#17/205 |
| Performance | ||
| 1Y Return | 57.56% | US#401/3,121 Sec#41/205 |
| 1M Return | -5.93% | US#1,788/3,121 Sec#143/205 |
| From 52W High | -41.22% | US#2,469/3,121 Sec#163/205 |
| 1Y MDD | -34.25% | US#1,698/3,121 Sec#91/205 |
| Trading | ||
| Volume | 398,087 shares | US#2,144/3,121 Sec#153/205 |
| Trading Value | $9M | US#2,374/3,121 Sec#158/205 |
| Per Share | ||
| EPS | $1.10 | US#1,650/3,121 Sec#86/205 |
| BPS | $9.92 | US#1,850/3,121 Sec#108/205 |
Company Info
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.